-
。Angiogenesis inhibitor 3 抑制 HUVEC 和 HCT-15 细胞的增殖,IC50 分别为 1.00 和 0.71 μM。Angiogenesis inhibitor 3 诱导 HUVEC 和 HCT-15 细胞凋亡
-
。Angiogenesis inhibitor 2 抑制 HUVEC 和 HCT-15 细胞的增殖,IC50 分别为 1.93 和 0.21 μM。Angiogenesis inhibitor 2 诱导 HUVEC 和 HCT-15 细胞凋亡
-
)、非小细胞肺癌 (NCI-H460)、结肠癌 (HCT 116 和 HCT-15) 和黑色素瘤 (LOX IMVI) 细胞系。WES-1 (Compound 8g) 是 碳酸酐酶 IX 的抑制剂 (Ki: 55.9 Μm)。WES-1 对
-
; 56 nM; 160 nMIn vitroIn HCT116 KRAS-mutant colorectal cancer cells, CH5126766 significantly reduces the levels
-
溶解度: DMSO : 55 mg/mL (152.2 mM)关键字: Cyclooxygenase | Inhibitor | COX | inhibit | HCT-1206 | Nitroflurbiprofen | HCT1206相关
-
cytotoxicity(HL-60, HCT116 and HCT15 cells with IC50s of 4.8 nM, 42.8 nM and 24.9 nM, respectively). S516 (30 nM; 16 hours
-
胆固醇生物合成并发挥细胞毒性作用。它是一种预防和干预APC 突变型结直肠癌的潜在治疗策略。体外活性: In two authentic human CRC cell lines HCT116 (WT APC) and DLD1
-
: human colorectal cancer HCT116, HT-29 and LoVo cells Concentration: 50, 100, 200 nM Incubation Time: 24, 48, and 72 hours
-
DNA 甲基转移酶 1 (DNMT1) 的特异性强效抑制剂。Procainamide 是一种 1A 类抗心律失常药物。Procainamide 具有研究癌症和心律失常的潜力。体外活性: HCT116, HCT116 DNMT1
-
that is both potent and selective. The IC(50) value for pERK inhibition in HCT116 tumours by G-573 was estimated to be 0.406